Alliance Calls on DEA to Rescind or Revise Telemedicine Rule

The Alliance appreciates the DEA’s forward movement on telemedicine prescribing of controlled substances policy. However, the Alliance continues to be concerned to see language in the proposed rulemaking mandating in-person visits as this is not an appropriate guardrail for a telehealth service. Similarly, restricting the geography in which telemedicine can be offered undermines the value [...]

2025-03-19T11:15:27-04:00March 19th, 2025|

Over 150 Stakeholders Send Letter to DEA

The Alliance for Connected Care led a letter, signed by more than 150 organizations, to the Attorney General Pam Bondi requesting her leadership in maintaining the access to telehealth that President Trump initiated during his first term. More than 150 organizations have signed this letter, including business groups like the Small Business & Entrepreneurship Council and [...]

2025-02-21T11:55:47-04:00February 20th, 2025|

Alliance Statement – DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES SPECIAL REGISTRATION PROPOSAL

ALLIANCE STATEMENT DRUG ENFORCEMENT ADMINISTRATION (DEA) RELEASES SPECIAL REGISTRATION PROPOSAL JANUARY 2025 The Alliance for Connected Care appreciates the Drug Enforcement Administration’s (DEA) forward movement on telemedicine prescribing of controlled substances policy.  Today, the DEA released a notice of proposed rulemaking, which would establish a special registration framework and authorize three types of special registrations [...]

2025-01-15T16:18:35-04:00January 15th, 2025|

The Alliance Leads Almost 350 Stakeholders Urging for a Two Year Extension on DEA Telemedicine Flexibilities

FOR IMMEDIATE RELEASE MEDIA CONTACT Krista Drobac; kdrobac@connectwithcare.org Hundreds of Stakeholders Call on Federal Leaders to Ensure Patient Care is Not Interrupted by Expiring Prescribing Flexibilities WASHINGTON, D.C. September 10, 2024 – Today, more than 300 organizations asked Congress and the White House to intervene to ensure ongoing access to virtual prescribing for patients and [...]

2024-09-11T14:15:04-04:00September 10th, 2024|

Finally – Action on Prescribing Through Telehealth

Last week, we finally saw a proposed rule – “Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation” arrive at OMB.  We expect that this proposed rule will avert the current end of telehealth prescribing flexibility on December 31, 2024.  However, there remains significant risk [...]

2024-07-01T12:20:40-04:00June 17th, 2024|

Mental Health Groups Sent Letter on Schedule IIN Non-Narcotic Prescribing

Mental Health Groups Sent Letter on Schedule IIN Non-Narcotic Prescribing Mental health groups are pushing the agency to allow Schedule IIN non-narcotic drugs to be prescribed without an in-person visit. Those include stimulants used to treat attention-deficit/hyperactivity disorder. A coalition of mental health groups, including the American Psychiatric Association, the American Academy of Pediatrics [...]

2024-12-11T22:25:29-04:00June 11th, 2024|

Group Letter on DEA Special Telemedicine Registration

The Alliance worked to convene over 80 organizations in a letter to the Drug Enforcement Administration (DEA) calling on the DEA to finalize the special registration for telemedicine. The anticipated registration would enable a practitioner to deliver, distribute, dispense, or prescribe via telemedicine a controlled substance to a patient who has not been medically examined [...]

2024-04-12T17:00:50-04:00October 26th, 2020|
Go to Top